Tecan Group AG (LON:0QLN)
London · Delayed Price · Currency is GBP · Price in CHF 140.70
+0.96 (0.68%)
Jan 27, 2026, 5:04 PM GMT
Tecan Group AG Market Cap
Tecan Group AG has a market cap or net worth of 1.69 billion as of January 27, 2026. Its market cap has decreased by -30.59% in one year.
Market Cap
1.69B
Enterprise Value
1.62B
Revenue
832.06M
Ranking
n/a
PE Ratio
29.11
Stock Price
140.70
Market Cap Chart
Since June 3, 1999, Tecan Group AG's market cap has increased from 45.11M to 1.69B, an increase of 3,638.60%. That is a compound annual growth rate of 14.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 1.69B | 10.06% |
| Dec 30, 2025 | 1.53B | -33.08% |
| Dec 30, 2024 | 2.29B | -44.06% |
| Dec 29, 2023 | 4.09B | -13.15% |
| Dec 30, 2022 | 4.71B | -17.44% |
| Dec 30, 2021 | 5.71B | 32.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.61B |
| GSK plc | 72.26B |
| Haleon | 33.83B |
| Smith & Nephew | 10.41B |
| Hikma Pharmaceuticals | 3.44B |
| HUTCHMED (China) | 1.93B |
| Genus | 1.88B |
| Oxford Nanopore Technologies | 1.65B |